Many inferior vena cava (IVC) anomalies remain asymptomatic because of collateral circulation, but thrombosis of these channels can cause acute deep venous thrombosis with serious sequelae. For those with threatened limbs, anticoagulation is the mainstay of treatment, with endovascular pharmacomechanical thrombolysis replacing open surgical thrombectomy. Described is a severe case of massive iliocaval deep venous thrombosis with bilateral lower extremity Rutherford IIb acute limb ischemia in a patient with congenital IVC atresia. After initial thrombolysis, endovascular IVC reconstruction was accomplished to decompress the lower extremities. The patient ultimately required a right throughknee amputation but remains ambulatory with a prosthetic. (J Vasc Surg Cases and Innovative Techniques 2019;5:438-42.) 
Many inferior vena cava (IVC) anomalies remain clinically silent because of well-developed collateral circulation; however, thrombosis of these channels can have serious sequelae, including phlegmasia cerulea dolens, renal vein thrombosis, and venous ulceration. 1, 2 Documented is the use of endovascular pharmacomechanical thrombolysis, infradiaphragmatic to supradiaphragmatic continuous renal replacement therapy (CRRT), and endovascular IVC reconstruction to treat a case of massive iliocaval deep venous thrombosis (DVT).
CASE REPORT
A 47-year-old man presented to the emergency department with bilateral lower extremity Rutherford IIb acute limb ischemia. He was unable to move his ankles and toes bilaterally, with sensory loss through the thigh, loss of arterial signals below the femoral arteries, and tight lower extremity compartments.
He had no known hypercoagulability and normal results of laboratory evaluation on presentation. Computed tomography (CT) angiography of the chest, abdomen, and pelvis with lower extremity runoff demonstrated no acute aortoiliac arterial disease, but there was no contrast opacification below the superficial femoral arteries bilaterally, concerning for occlusion.
Although there was no delayed phase, extensive thrombus was seen in the IVC and iliac veins with an associated suprarenal IVC atresia and enlarged collaterals (azygos and lumbar veins; achieving through-and-through wire access. This segment was predilated with a 10-mm balloon (Fig 3) , and intravascular ultrasound was used to mark the proximal and distal landing zones. Four Wallstents (Boston Scientific) were deployed from the hepatic veins through the left external iliac vein to create a neo-IVC and to cover residual thrombus. Repeated intravascular ultrasound measured a 14-mm lumen in the previously atretic portion and >16 mm throughout the infrarenal IVC and iliac veins (Fig 4) .
Completion venography confirmed a patent reconstruction
with in-line outflow from the lower extremities to the heart ( Fig 5) . 
DISCUSSION
Historically, treatment of an iliocaval DVT focused on reducing angiospasm, preventing propagation of thrombus, and treating underlying conditions. 3 Open thrombectomy offered the first paradigm shift, and since the 1990s, treatment has focused on resuscitation, anticoagulation, thrombectomy, and thrombolysis. [4] [5] [6] [7] [8] [9] [10] Whereas contemporary series of open and endovascular venous treatments have demonstrated similar success when used in combination with iliocaval stenting, 9, 10 open thrombectomy is most effective when there is already established outflow through the IVC. In this case, open thrombectomy would not address the thrombosed collateral veins needed to re-establish baseline anatomy. Using endovascular thrombolysis, our followup venogram demonstrated flow in several collaterals, which helped to further offload the venous hypertension. One downside to endovascular treatment is the prolonged time needed for tPA to take effect. To quickly decrease the lower extremity venous hypertension in our patient, we used a novel technique for jugularfemoral venovenous bypass using a CRRT machine as a pump with infradiaphragmatic outflow and supradiaphragmatic return. A decrease in the IVC pressure from 100 mm Hg to 50 mm Hg was seen during the first 24 hours. This technique also allowed filtration of the lower extremity blood in anticipation of rhabdomyolysis, hyperkalemia, and lactic acidosis. This technique for venovenous bypass was beneficial in our patient but may not be necessary in those who already have in-line outflow from the lower extremities through a patent IVC.
Few recent series discuss the safety and efficacy of IVC recanalization in patients with chronic occlusions. The durability of this technique rivals iliac vein stenting with 4-year follow-up primary, primary assisted, and secondary patency of 52% to 78%, 85% to 87%, and 91% to 93%. 11, 12 When encroaching on the renal or hepatic veins, other groups prefer the Gianturco Z stents (Cook Medical, Bloomington, Ind) as their wide interstices allow better cross-flow, but these were unavailable at our institution. Although we jailed the renal veins, we maximized the interstices of the Wallstent by ballooning them to profile. However, the risk remains for future renal vein obstruction due to pseudointima formation within the stent.
CONCLUSIONS
Aggressive venous thrombolytics and endovascular IVC reconstruction were successful in this unusual case of massive iliocaval DVT and associated IVC atresia. The technique of venovenous bypass with CRRT was a novel adjunct to decrease the venous pressure while also filtering the metabolic toxins.
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